Stay updated on Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial
Sign up to get notified when there's something new on the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page.

Latest updates to the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new revision entry (v3.6.4) was added to the study record history, replacing the previous revision (v3.6.3). This indicates an update to the study record metadata on the page.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe history now records Revision: v3.6.3 as the latest entry, replacing the previous Revision: v3.6.2. This reflects a small update to the page's revision tracking rather than any changes to study data or content.SummaryDifference0.1%

- Check39 days agoChange DetectedNew revision entry v3.6.2 has been added to the study's record history, and the prior v3.6.0 entry was removed. This reflects an update to the versioning history displayed on the page.SummaryDifference0.1%

- Check53 days agoChange DetectedA new 'Check who can join' option and a 'Find Contact Information' link were added to the study record history to support recruitment and access to contact details. The changes also include adding the v3.6.0 revision and removing the previous v3.5.5 entry.SummaryDifference0.6%

- Check61 days agoChange DetectedA new revision entry v3.5.5 was added to the study's history, replacing the previous v3.5.4 in the page's version history.SummaryDifference0.1%

- Check82 days agoChange DetectedThe footer revision label was updated from v3.5.3 to v3.5.4, indicating a new release of the site's interface. This change represents a software version update rather than changes to the study record content.SummaryDifference0.1%

Stay in the know with updates to Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page.